Prevalence of Vitreous Hemorrhage Following Coronary Revascularization in Patients With Diabetic Retinopathy

被引:3
|
作者
Kawashima, Dai [1 ]
Ohno, Takayuki [5 ]
Kinoshita, Osamu
Motomura, Noboru
Kiyosue, Arihiro [2 ]
Fujita, Hideo [2 ]
Ando, Jiro [2 ]
Ohtomo, Kazuyoshi [3 ]
Shigeeda, Takashi [3 ]
Kato, Satoshi [3 ]
Kadowaki, Takashi [4 ]
Nagai, Ryozo [2 ]
Takamoto, Shinichi [5 ]
Ono, Minoru
机构
[1] Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Dept Cardiol, Tokyo 1138655, Japan
[3] Univ Tokyo, Dept Ophthalmol, Tokyo 1138655, Japan
[4] Univ Tokyo, Dept Endocrinol & Metab, Tokyo 1138655, Japan
[5] Mitsui Mem Hosp, Dept Cardiovasc Surg, Tokyo 101, Japan
关键词
Coronary artery bypass surgery; Coronary revascularization; Diabetic retinopathy; Drug-eluting stent implantation; Vitreous hemorrhage; DUAL ANTIPLATELET THERAPY; PREMATURE DISCONTINUATION; HEART-ASSOCIATION; AMERICAN-COLLEGE; MORTALITY; MELLITUS; DISEASE;
D O I
10.1253/circj.CJ-10-0404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In patients with diabetic retinopathy (DR), vitreous hemorrhage (VH) is a common complication that threatens visual acuity and hence, quality of life. A considerable number of DR patients at risk of VH require coronary revascularization, but little is known about the prevalence of VH after coronary revascularization. Methods and Results: This study investigated 151 patients with DR who were followed up by ophthalmologists between April 2004 and September 2008, and underwent coronary revascularization (coronary artery bypass surgery n=36 or drug-eluting stent implantation n=115). At the time of coronary revascularization 56 had non-proliferative DR (NPDR) and 95 had proliferative DR (PDR). During an average follow-up of 531 days after revascularization, VH occurred in 24 (15.9%) patients, 18 (11.9%) of whom experienced VH within 6 months of the procedure. In VH patients, PDR rather than NPDR predominated as the background to VH (21 vs. 3, respectively). The 1-year prevalence of VH was higher in patients with PDR than in those with NPDR (22.0% vs. 1.9%, P=0.0055). Conclusions: VH is not a rare complication following coronary revascularization among patients with DR, especially in those with PDR. Thus, in terms of maintaining quality of life, VH after coronary revascularization needs further attention in these patients. (Circ J 2011; 75: 329-335)
引用
收藏
页码:329 / 335
页数:7
相关论文
共 50 条
  • [31] Vitreous hemorrhage after tooth extraction in a patient with proliferative diabetic retinopathy
    Masuda, Issei
    Kondo, Keisuke
    Kaneko, Takahiro
    Horie, Norio
    Shimoyama, Tetsuo
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2016, 28 (02) : 162 - 164
  • [33] Sarcoid retinopathy with vitreous hemorrhage
    Harada, T
    Goto, H
    Kosaka, M
    Sakamoto, R
    Ishikawa, R
    Majima, Y
    SOE '97 - XI CONGRESS OF THE EUROPEAN SOCIETY OF OPHTHALMOLOGY, VOLS 1 AND 2, 1997, : 1457 - 1461
  • [34] THE RISK OF VITREOUS HEMORRHAGE CAUSED BY CORONARY-ARTERY BYPASS-GRAFTING IN PROLIFERATIVE DIABETIC-RETINOPATHY
    SMALL, KW
    BUCKLEY, EG
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1990, 99 (01): : 176 - 177
  • [35] Ghost Cell Glaucoma After Intravitreal Bevacizumab for Postoperative Vitreous Hemorrhage Following Vitrectomy for Proliferative Diabetic Retinopathy
    Lin, Laura
    Wu, Wei-Chi
    Yeung, Ling
    Wang, Nan-Kai
    Kuo, Ya-Hui
    Chao, An-Ning
    Chen, Kuan-Jen
    Chen, Ten-Lu
    Lai, Chi-Chun
    Hwang, Yih-Shiou
    Chen, Yen-Po
    OPHTHALMIC SURGERY LASERS & IMAGING, 2010, 41 (01) : 72 - 77
  • [36] Increased osteopontin levels in the vitreous of patients with diabetic retinopathy
    Kase, Satoru
    Yokoi, Masahiko
    Saito, Wataru
    Furudate, Naoki
    Ohgami, Kazuhiro
    Kitamura, Mizuki
    Kitaichi, Nobuyoshi
    Yoshida, Kazuhiko
    Kase, Manabu
    Ohno, Shigeaki
    Uede, Toshimitsu
    OPHTHALMIC RESEARCH, 2007, 39 (03) : 143 - 147
  • [37] Total antioxidant power in the vitreous of diabetic retinopathy patients
    Matsuno, K
    Osako, M
    Usui, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [38] CYTOKINES IN THE VITREOUS OF PATIENTS WITH PROLIFERATIVE DIABETIC-RETINOPATHY
    ELASRAR, AM
    MAIMONE, D
    MORSE, PH
    GREGORY, S
    REDER, AT
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 114 (06) : 731 - 736
  • [39] Vitreous and serum concentration of cytokines in patients with diabetic retinopathy
    Valente, Stefano
    Mafrici, Marco
    Trabucco, Paolo
    Diana, Cristina
    Marcelli, Michela
    Spadea, Leopoldo
    Vingolo, Enzo M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [40] Serum and Vitreous Levels of Visfatin in Patients with Diabetic Retinopathy
    Wang, Yongqiang
    Yuan, Ye
    Jiang, Hua
    MEDICAL SCIENCE MONITOR, 2014, 20 : 2729 - 2732